Swedbank’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175M Sell
322,995
-4,127
-1% -$2.32M 0.15% 115
2026
Q1
$194M Buy
327,122
+2,350
+0.7% +$1.17M 0.2% 91
2025
Q4
$158M Sell
324,772
-4,346
-1% -$2.02M 0.15% 112
2025
Q3
$138M Sell
329,118
-1,499
-0.5% -$504K 0.14% 122
2025
Q2
$95M Buy
330,617
+104
+0% +$31.1K 0.11% 153
2025
Q1
$102M Sell
330,513
-4,992
-1% -$1.71M 0.14% 133
2024
Q4
$118M Sell
335,505
-79,432
-19% -$29.2M 0.15% 116
2024
Q3
$149M Sell
414,937
-7,718
-2% -$2.61M 0.19% 106
2024
Q2
$135M Sell
422,655
-975
-0.2% -$258K 0.18% 100
2024
Q1
$97.3M Buy
423,630
+10,463
+3% +$2.36M 0.85% 5
2023
Q4
$90.9M Sell
413,167
-4,780
-1% -$1.1M 0.15% 123
2023
Q3
$94.4M Buy
417,947
+12,645
+3% +$2.91M 0.16% 112
2023
Q2
$89.5M Sell
405,302
-2,779
-0.7% -$616K 0.15% 116
2023
Q1
$91.4M Sell
408,081
-1,710
-0.4% -$422K 0.18% 109
2022
Q4
$114M Sell
409,791
-2,784
-0.7% -$703K 0.25% 87
2022
Q3
$86.4M Hold
412,575
0.21% 99
2022
Q2
$97.2M Sell
412,575
-6,643
-2% -$1.35M 0.22% 98
2022
Q1
$75.2M Buy
419,218
+6,104
+1% +$1.16M 0.14% 141
2021
Q4
$88.9M Hold
413,114
0.15% 136
2021
Q3
$76.3M Hold
413,114
0.14% 139
2021
Q2
$74.1M Hold
413,114
0.14% 141
2021
Q1
$69.1M Buy
+413,114
New +$68.9M 0.14% 146

Other funds holding UTHR

Swedbank's UTHR Position: Q2 2026 in Review

Swedbank reduced its United Therapeutics (UTHR) stake by 1.3% in Q2 2026, selling an estimated $2.32M and leaving 322,995 shares worth $175M. The position accounts for 0.15% of the portfolio, ranked #115.

Swedbank first reported a position in UTHR in Q1 2021 and has held it in 22 quarters since. The position peaked at $194M in Q1 2026. 83 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Swedbank held 322,995 shares of United Therapeutics worth $175M as of Q2 2026.
  • Swedbank sold 4,127 United Therapeutics shares in Q2 2026, an estimated $2.32M.
  • United Therapeutics made up 0.15% of Swedbank's portfolio in Q2 2026, its #115 holding.
  • Swedbank first reported a position in United Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Swedbank's United Therapeutics position peaked at $194M in Q1 2026.
  • 83 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.